The impact of opioid-induced hyperalgesia for postoperative pain
Tóm tắt
Từ khóa
Tài liệu tham khảo
Beck, 1974, Bradykinin and serotonin effects on various types of cutaneous nerve fibers, Pflügers Archiv: European Journal of Physiology, 347, 209, 10.1007/BF00592598
Bessou, 1969, Responses of cutaneous sensory units with unmyelinated fibers to noxious stimuli, Journal of Neurophysiology, 32, 1025, 10.1152/jn.1969.32.6.1025
Meyer, 1981, Myelinated nociceptive afferents account for the hyperalgesia that follows a burn to the hand, Science, 213, 1527, 10.1126/science.7280675
Reeh, 1987, Sensitization of nociceptive cutaneous nerve fibers from the rat's tail by noxious mechanical stimulation, Experimental Brain Research, 65, 505, 10.1007/BF00235973
Schmelz, 1996, Limitation of sensitization to injured parts of receptive fields in human skin C-nociceptors, Experimental Brain Research, 109, 141, 10.1007/BF00228635
Schmidt, 1995, Novel classes of responsive and unresponsive C nociceptors in human skin, The Journal of Neuroscience, 15, 333, 10.1523/JNEUROSCI.15-01-00333.1995
Ali, 1996, Secondary hyperalgesia to mechanical but not heat stimuli following a capsaicin injection in hairy skin, Pain, 68, 401, 10.1016/S0304-3959(96)03199-5
LaMotte, 1991, Neurogenic hyperalgesia psychophysical studies of underlying mechanisms, Journal of Neurophysiology, 66, 190, 10.1152/jn.1991.66.1.190
Raja, 1984, Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin, Brain, 107, 1179, 10.1093/brain/107.4.1179
Simone, 1989, Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin, Pain, 38, 99, 10.1016/0304-3959(89)90079-1
Dickenson, 1995, Spinal cord pharmacology of pain, British Journal of Anaesthesia, 75, 193, 10.1093/bja/75.2.193
Schaible, 1991, The effects of NMDA antagonists on neuronal activity in cats spinal cord evoked by acute inflammation in the knee joint, The European Journal of Neuroscience, 3, 981, 10.1111/j.1460-9568.1991.tb00034.x
Woolf, 1991, The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states, Pain, 44, 293, 10.1016/0304-3959(91)90100-C
Abram, 1993, Morphine, but not inhalation anesthesia, blocks post-injury facilitation, Anesthesiology, 78, 713, 10.1097/00000542-199304000-00015
Dahl, 1993, The value of pre-emptive analgesia in the treatment of postoperative pain, British Journal of Anaesthesia, 70, 434, 10.1093/bja/70.4.434
Dahl, 1990, Prevention of postoperative pain by balanced analgesia, British Journal of Anaesthesia, 64, 518, 10.1093/bja/64.4.518
Kehlet, 1989, Surgical stress: the role of pain and analgesia, British Journal of Anaesthesia, 63, 189, 10.1093/bja/63.2.189
Kehlet, 1997, Multimodal approach to control postoperative pathophysiology and rehabilitation, British Journal of Anaesthesia, 708, 606, 10.1093/bja/78.5.606
Kehlet, 1993, The value of multimodal or balanced analgesia in postoperative pain treatment, Anesthesia and Analgesia, 77, 1048, 10.1213/00000539-199311000-00030
Woolf, 1993, Preemptive analgesia – treating postoperative pain by preventing the establishment of central sensitization, Anesthesia and Analgesia, 77, 362, 10.1213/00000539-199377020-00026
Kest, 2000, Gender-differences in opioid-mediated analgesia: animal and human studies, Anesthesiology, 93, 539, 10.1097/00000542-200008000-00034
Pleym, 2003, Gender differences in drug effects: implications for anesthesiologists, Acta Anaesthesiologica Scandinavica, 47, 241, 10.1034/j.1399-6576.2003.00036.x
Freye, 2003, Toleranzentwicklung unter Opioidgabe – Molekulare Mechanismen und klinische Bedeutung, Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie, 38, 14, 10.1055/s-2003-36558
Kissin, 2001, Can inflammatory pain prevent the development of acute tolerance to alfentanil?, Anesthesia and Analgesia, 92, 1296, 10.1097/00000539-200105000-00041
Ali, 1986, Hyperalgesic response in a patient receiving high concentrations of spinal morphine, Anesthesiology, 65, 449, 10.1097/00000542-198610000-00028
Arner, 1988, Clinical experience of long-term treatment with epidural and intrathecal opioids – a nationwide survey, Acta Anaesthesiologica Scandinavica, 32, 253, 10.1111/j.1399-6576.1988.tb02725.x
Doverty, 2001, Hyperalgesic responses in methadone maintenance patients, Pain, 90, 91, 10.1016/S0304-3959(00)00391-2
Guignard, 2000, Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement, Anesthesiology, 93, 409, 10.1097/00000542-200008000-00019
Angst, 2006, Opioid-induced hyperalgesia, Anesthesiology, 104, 570, 10.1097/00000542-200603000-00025
Celerier, 1999, Evidence for opiate-activated NMDA processes masking opiate analgesia in rats, Brain Research, 847, 18, 10.1016/S0006-8993(99)01998-8
Colpaert, 1996, System theory of pain and of opiate analgesia: no tolerance to opiates, Pharmacological Reviews, 48, 402
Ossipov, 2003, Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance, Life Sciences, 73, 783, 10.1016/S0024-3205(03)00410-7
Simonnet, 2003, Opioid-induced hyperalgesia: abnormal or normal pain, Neuroreport, 14, 1, 10.1097/00001756-200301200-00001
Solomon, 1974, An opponent-process theory of motivation, Psychological Review, 81, 119, 10.1037/h0036128
Connor, 1999, Opiod receptor signalling mechanisms, Clinical and Experimental Pharmacology & Physiology, 26, 493, 10.1046/j.1440-1681.1999.03049.x
Claphan, 1997, G protein βγ subunits, Annual Review of Pharmacology and Toxicology, 37, 167, 10.1146/annurev.pharmtox.37.1.167
Aimone, 1989, Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo, Peptides, 10, 1127, 10.1016/0196-9781(89)90003-X
Chang, 1989, Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions, Anesthesiology, 70, 672, 10.1097/00000542-198904000-00022
Trafton, 1999, Spinal opioid analgesia: how critical is the regulation of substance P signaling, The Journal of Neuroscience, 19, 9642, 10.1523/JNEUROSCI.19-21-09642.1999
Borgland, 2001, Acute opioid receptor desensitization and tolerance: is there a link?, Clinical and Experimental Pharmacology & Physiology, 28, 147, 10.1046/j.1440-1681.2001.03418.x
He, 2002, Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization, Cell, 108, 271, 10.1016/S0092-8674(02)00613-X
Kieffer, 2002, Opioid tolerance – in search of the holy grail, Cell, 108, 587, 10.1016/S0092-8674(02)00666-9
Keith, 1996, Morphine activates opioid receptors without causing their rapid internalization, The Journal of Biological Chemistry, 271, 19021, 10.1074/jbc.271.32.19021
Whistler, 1999, Functional dissociation of m Opioid receptor signalling and endocytosis: implications for the biology of opiate tolerance and addiction, Neuron, 23, 737, 10.1016/S0896-6273(01)80032-5
Fields, 1983, The activity of neurons in the rostral medulla of the rat during wthdrawal from noxious heat, The Journal of Neuroscience, 3, 2545, 10.1523/JNEUROSCI.03-12-02545.1983
Fields, 1985, Anatomy and physiology of a nociceptive modulatory system, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 308, 361, 10.1098/rstb.1985.0037
Morgan, 1994, Pronounced changes in the activity of nociceptive modulatory neurons in the rostral ventromedial medulla in response to prolonged thermal noxious stimuli, Journal of Neurophysiology, 72, 1161, 10.1152/jn.1994.72.3.1161
Fields, 1991, Neurotransmitters in nociceptive modulatory circuits, Annual Review of Neuroscience, 14, 219, 10.1146/annurev.ne.14.030191.001251
Heinricher, 1992, Direct and indirect actions of morphine on medullary neurons that modulate nociception, Neuroscience, 48, 533, 10.1016/0306-4522(92)90400-V
Heinricher, 1994, Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla, Neuroscience, 63, 279, 10.1016/0306-4522(94)90022-1
Chieng, 1998, Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal, The Journal of Neuroscience, 18, 7033, 10.1523/JNEUROSCI.18-17-07033.1998
Dickenson, 1997, The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord, General Pharmacology, 28, 633, 10.1016/S0306-3623(96)00359-X
Duttaroy, 1995, The effects of intrinsic efficacy on opioid tolerance, Anesthesiology, 82, 1226, 10.1097/00000542-199505000-00018
Basbaum, 1999, Distinct neurochemical features of acute and persistent pain, Proceedings of the National Academy of Sciences of the United States of America, 96, 7739, 10.1073/pnas.96.14.7739
Martin, 1999, Inflammation-induced up-regulation of protein kinase Cgamma immunoreactivity in rat spinal cord correlates with enhanced nociceptive processing, Neuroscience, 88, 1267, 10.1016/S0306-4522(98)00314-5
Mayer, 1999, Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions, Proceedings of the National Academy of Sciences of the United States of America, 96, 7731, 10.1073/pnas.96.14.7731
Mayer, 1995, The development of morphine tolerance and dependence is associated with translocation of protein kinase C, Pain, 61, 365, 10.1016/0304-3959(95)00023-L
Appleyard, 2003, Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin, The Journal of Biological Chemistry, 27, 23802
Kovoor, 1998, Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy, Molecular Pharmacology, 54, 704
Bot, 1998, Fentanyl and its analogs desensitize the cloned mu opioid receptor, The Journal of Pharmacology and Experimental Therapeutics, 285, 1207
Keith, 1998, Mu-opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechansim in vitro and in the mammalian brain, Molecular Pharmacology, 53, 377, 10.1124/mol.53.3.377
Angers, 2002, Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function, Annual Review of Pharmacology and Toxicology, 42, 409, 10.1146/annurev.pharmtox.42.091701.082314
Jordan, 1999, G-protein coupled receptor heterodimerization modulates receptor function, Nature, 399, 700, 10.1038/21447
Avidor-Reiss, 1996, Chronic opioid treatment induces adenyl cyclase V superactivation, The Journal of Biological Chemistry, 271, 21309, 10.1074/jbc.271.35.21309
Crain, 1998, Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1ganglioside-regulated opioid receptor functions, Trends in Pharmacological Sciences, 19, 358, 10.1016/S0165-6147(98)01241-3
Sharma, 1975, Morphine receptors as regulators of adenylate cyclase activity, Proceedings of the National Academy of Sciences of the United States of America, 72, 590, 10.1073/pnas.72.2.590
Fairbanks, 2000, Spinal plasticity of acute opioid tolerance, Journal of Biomedical Science, 7, 200, 10.1007/BF02255467
Li, 2002, Hyperalgesia during opioid abstinence: mediation by glutamate and substance P, Anesthesia and Analgesia, 95, 979, 10.1213/00000539-200210000-00035
Ingram, 1998, Enhanced opioid efficacy in opioid dependence is due to an additional signal transduction pathway, The Journal of Neuroscience, 18, 10269, 10.1523/JNEUROSCI.18-24-10269.1998
Kissin, 1992, Does midazolam inhibit the development of acute tolerance to the analgesic effect of alfentanil?, Life Sciences, 52, 55
Kissin, 1997, Effect of midazolam on development on acute tolerance to alfentanil: the role of pharmacokinetic interactions, Anesthesia and Analgesia, 85, 182, 10.1213/00000539-199707000-00032
Luger, 1994, Mechanisms of the influence of midazolame on morphine antinociception at spinal and supraspinal levels in rats, European Journal of Pharmacology, 271, 421, 10.1016/0014-2999(94)90802-8
Luger, 1995, The spinal potentiating effect and the supraspinal inhibitory effect of midazolam on opioid-induced analgesia, European Journal of Pharmacology, 275, 153, 10.1016/0014-2999(94)00759-Z
Tejwani, 1993, Inhibition of morphine-induced tolerance and dependence by a benzodiazepine receptor agonist midazolam in the rat, Anesthesia and Analgesia, 76, 1052, 10.1213/00000539-199305000-00025
Elliott, 1994, The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to th mu-opioid morphine but not to kappa opioids, Pain, 56, 69, 10.1016/0304-3959(94)90151-1
Kolesnikov, 1993, Blockade of tolerance to morphine but not to k opioids by a nitric oxide synthese inhibitor, Proceedings of the National Academy of Sciences of the United States of America, 90, 5162, 10.1073/pnas.90.11.5162
Majeed, 1994, Inhibition of nitric oxide synthetase attenuates the development of morphine tolerance and dependence in mice, Neuropharmacology, 32, 189, 10.1016/0028-3908(94)90006-X
Przewlocki, 1993, Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord, Life Sciences, 53, 1, 10.1016/0024-3205(93)90615-A
Mao, 1997, The inhibition of nitric oxide-activated poly(ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat, Pain, 72, 355, 10.1016/S0304-3959(97)00063-8
Goldstein, 1979, Dynorphin-(1-13), an extraordinarily potent opioid peptide, Proceedings of the National Academy of Sciences of the United States of America, 76, 6666, 10.1073/pnas.76.12.6666
Faden, 1992, Dynorphin increases extracellular levels of excitatory amino acids in the brain trough a non-opioid mechanism, The Journal of Neuroscience, 12, 425, 10.1523/JNEUROSCI.12-02-00425.1992
Gardell, 2002, Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers, The Journal of Neuroscience, 22, 6747, 10.1523/JNEUROSCI.22-15-06747.2002
Skilling, 1992, Selective potentiation on NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity, Brain Research, 575, 272, 10.1016/0006-8993(92)90090-V
Benoliel, 1991, Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation, Neuroscience Letters, 124, 204, 10.1016/0304-3940(91)90094-A
Bourgoin, 1994, Opioidergic control of the spinal release of neuropetides. Possible significance for the analgesic effects of opioids, Fundamental & Clinical Pharmacology, 8, 307, 10.1111/j.1472-8206.1994.tb00809.x
Devillers, 1995, Release of neuropeptide FF, an anti-opioid peptide, in rat spinal cord slices is voltage- and Ca(2+)-sensitive: possible involvement of P-type Ca2+ channels, Journal of Neurochemistry, 64, 1567, 10.1046/j.1471-4159.1995.64041567.x
Devillers, 1995, Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats, Brain Research, 700, 173, 10.1016/0006-8993(95)00948-P
Gouarderes, 1999, Nociceptin receptors in the rat spinal cord during morphine tolerance, Brain Research, 838, 85, 10.1016/S0006-8993(99)01713-8
Rattan, 1997, Effect of chronic treatment with morphine, midazolame and both together on dynorphin(1-3) levels in the rat, Brain Research, 754, 239, 10.1016/S0006-8993(97)00084-X
Xu, 1993, Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat, Neuroscience Letters, 152, 129, 10.1016/0304-3940(93)90500-K
Yang, 1985, Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine, Proceedings of the National Academy of Sciences of the United States of America, 82, 7757, 10.1073/pnas.82.22.7757
Yuan, 1999, Accelerated release and production of orphanin FQ in the brain of chronic morphine tolerant rats, Brain Research, 826, 330, 10.1016/S0006-8993(99)01337-2
Rizzi, 2000, The nociceptin/orphanin FQ receptor antagonist, [Nphe1]NC(1-13)NH2, potentiates morphine analgesia, Neuroreport, 11, 2369, 10.1097/00001756-200008030-00007
Vanderah, 2000, Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance, The Journal of Neuroscience, 20, 7074, 10.1523/JNEUROSCI.20-18-07074.2000
Vanderah, 2001, Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin, Pain, 92, 5, 10.1016/S0304-3959(01)00311-6
Watkins, 1984, Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide, Science, 224, 395, 10.1126/science.6546809
Watkins, 1985, Potentiation of morphine analgesia by the cholecystokinin antagonists proglumide, Brain Research, 327, 169, 10.1016/0006-8993(85)91511-2
Kaplan, 1991, Hyperalgesia during acute opioid abstinence: evidence for a nociceptive facilitating function of the rostral ventromedial medulla, The Journal of Neuroscience, 11, 1433, 10.1523/JNEUROSCI.11-05-01433.1991
Vanderah, 2001, Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance, The Journal of Neuroscience, 21, 279, 10.1523/JNEUROSCI.21-01-00279.2001
Heinricher, 1997, Circuitry underlying antiopioid action of orphanin FQ in the rostral ventromedial medulla, Journal of Neurophysiology, 78, 3351, 10.1152/jn.1997.78.6.3351
Heinricher, 2001, Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla, Journal of Neurophysiology, 85, 280, 10.1152/jn.2001.85.1.280
Bie, 2003, Presynaptic mechanism for anti-analgesic and anti-hyperalgesic actions of k-opioid receptors, The Journal of Neuroscience, 23, 7262, 10.1523/JNEUROSCI.23-19-07262.2003
Pasternak, 1987, Morphine-6-glucuronide, a potent mu agonist, Life Sciences, 41, 2845, 10.1016/0024-3205(87)90431-0
Shimomura, 1971, Analgesic effects of morphine glucuronides, The Tohoku Journal of Experimental Medicine, 105, 45, 10.1620/tjem.105.45
Smith, 1990, Morphine-3-glucuronide – a potent antagonist of morphine analgesia, Life Sciences, 47, 579, 10.1016/0024-3205(90)90619-3
Yaksh, 1998, Pharmakology of the allodynia in rats evoked by high dose intrathecal morphine, The Journal of Pharmacology and Experimental Therapeutics, 244, 501
Celerier, 2000, Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine, Anesthesiology, 92, 465, 10.1097/00000542-200002000-00029
Rivat, 2002, Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-d-aspartate receptor antagonist ketamine, Anesthesiology, 96, 381, 10.1097/00000542-200202000-00025
Laulin, 2002, The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance, Anesthesia and Analgesia, 94, 1263, 10.1097/00000539-200205000-00040
Richebe, 2003, Acute morphine tolerance in rats operated under fentanyl. Preventive effect of ketamine, Anesthesiology, 99, A941
Richebe, 2005, Nitrous oxide revisited: evidence for potent antihyperalgesic properties, Anesthesiology, 103, 845, 10.1097/00000542-200510000-00024
Chia, 1999, Intraoperative high dose fentanyl induces postoperative fentanyl tolerance, Canadian Journal of Anaesthesia, 46, 872, 10.1007/BF03012978
Kissin, 2000, Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-d-aspartate-nitric oxide systems, Anesthesia and Analgesia, 91, 110, 10.1213/00000539-200007000-00021
Kissin, 1996, Time course characteristics of acute tolerance development to continuously infused alfentanil in rats, Anesthesia and Analgesia, 83, 600, 10.1213/00000539-199609000-00029
Kissin, 2000, The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations?, Anesthesia and Analgesia, 91, 1483, 10.1097/00000539-200012000-00035
Schraag, 1999, Lack of rapid development of opioid tolerance during alfentanil and remifentanil infusions for postoperative pain, Anesthesia and Analgesia, 89, 753, 10.1213/00000539-199909000-00042
Vinik, 1998, Rapid development of tolerance to analgesia during remifentanil infusion in human, Anesthesia and Analgesia, 86, 1307, 10.1213/00000539-199806000-00033
Gustorff, 2001, The effect of remifentanil on the heat pain threshold in volunteers, Anesthesia and Analgesia, 92, 369, 10.1213/00000539-200102000-00017
Gustorff, 2002, The absence of acute tolerance during remifentanil infusion in volunteers, Anesthesia and Analgesia, 94, 1223, 10.1097/00000539-200205000-00032
Soltesz, 2001, Recovery after remifentanil and sufentanil for analgesia and sedation of mechanically ventilated patients after trauma or major surgery, British Journal of Anaesthesia, 86, 763, 10.1093/bja/86.6.763
Wilhelm, 1999, Remifentanil zur Analgosedierung von Intensivpatienten, Anaesthesist, 48, 625, 10.1007/s001010050762
Cortinez, 2001, No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia, British Journal of Anaesthesia, 87, 866, 10.1093/bja/87.6.866
Angst, 2003, Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal, Pain, 106, 49, 10.1016/S0304-3959(03)00276-8
Hood, 2003, Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia, Anesthesia and Analgesia, 97, 810, 10.1213/01.ANE.0000078811.80093.88
Koppert, 2003, Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans, Pain, 106, 91, 10.1016/S0304-3959(03)00294-X
Koppert, 2003, Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans, Anesthesiology, 99, 152, 10.1097/00000542-200307000-00025
Guignard, 2002, Supplementing desflurane-remifentanil anesthesia with small-dose ketamine reduces perioperative opioid analgesic requirements, Anesthesia and Analgesia, 95, 103, 10.1097/00000539-200207000-00018
Luginbühl, 2003, Modulation of remifentanil-induced analgesia, hyperalgesia and tolerance by small-dose ketamine in humans, Anesthesia and Analgesia, 96, 726, 10.1213/01.ANE.0000048086.58161.18
Mao, 1994, Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C, The Journal of Neuroscience, 14, 2301, 10.1523/JNEUROSCI.14-04-02301.1994
Stillman, 1987, Paradoxical pain following high-dose spinal morphine, Pain, 4
Li, 2001, Opioid-induced hyperalgesia and incisional pain, Anesthesia and Analgesia, 93, 204, 10.1097/00000539-200107000-00040
Li, 2001, A murine model of opioid-induced hyperalgesia, Brain Research. Molecular Brain Research, 86, 56, 10.1016/S0169-328X(00)00260-6
Manning, 1996, Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance, Pain, 67, 79, 10.1016/0304-3959(96)81972-5
Mao, 1996, Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats, Pain, 67, 361, 10.1016/0304-3959(96)03120-X
Mao, 1995, Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions, Pain, 62, 259, 10.1016/0304-3959(95)00073-2
Adriaenssens, 1999, Postoperative analgesia with i.v. patient-controlled morphine: effect of adding ketamine, British Journal of Anaesthesia, 83, 393, 10.1093/bja/83.3.393
Katz, 2000, Morphidex (MS:DM) double-blind, multiple-dose studies in chronic pain patients, Journal of Pain and Symptom Management, 19, S37, 10.1016/S0885-3924(99)00129-3
Weinbroum, 2003, A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain, Anesthesia and Analgesia, 96, 789, 10.1213/01.ANE.0000048088.17761.B4
Sjogren, 1993, Myoclonic spasms during treatment with high doses of intravenous morphine in renal failure, Acta Anaesthesiologica Scandinavica, 37, 780, 10.1111/j.1399-6576.1993.tb03809.x
Smith, 1995, Morphin-3-glucuronide: evidence to support its role in the development of tolerance to the antinozizeptive effects of morphine in the rat, Pain, 62, 51, 10.1016/0304-3959(94)00228-7
Smith, 2000, Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites, Clinical and Experimental Pharmacology & Physiology, 27, 524, 10.1046/j.1440-1681.2000.03290.x
Sjogren, 1994, Disappearence of morphine-induced hyperalgesia after discontinuing or substituting with other opioid agonists, Pain, 59, 313, 10.1016/0304-3959(94)90084-1
Ebert, 1995, Ketobemidone, methadone and pethidine are noncompetitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord, Neuroscience Letters, 187, 165, 10.1016/0304-3940(95)11364-3
Gorman, 1997, The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-d-aspartate (NMDA) receptor in rat forebrain and spinal cord, Neuroscience Letters, 223, 1
Carpenter, 2000, Neuronal inhibitory effects of methadone are predominantly opioid receptor mediated in the rat spinal cord in vivo, European Journal of Pain (London, England), 4, 19, 10.1053/eujp.1999.0147
Bulka, 2002, Reduced tolerance to the anti-hyperalgesic effect of methadone in comparison to morphine in a rat model of mononeuropathy, Pain, 95, 103, 10.1016/S0304-3959(01)00382-7
Doverty, 2001, Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine, Pain, 93, 155, 10.1016/S0304-3959(01)00306-2
Davis, 1999, D-methadone blocks morphine tolerance and N-methyl-d-aspartate-induced hyperalgesia, The Journal of Pharmacology and Experimental Therapeutics, 289, 1048
Stevens, 1989, Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion, The Journal of Pharmacology and Experimental Therapeutics, 250, 1
Compton, 2001, Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent, Drug and Alcohol Dependence, 63, 139, 10.1016/S0376-8716(00)00200-3
Clark, 2002, Comment on: Doverty, et al., Hyperalgesic responses in methadone maintenance patients, Pain, 99, 608, 10.1016/S0304-3959(02)00310-X
Larcher, 1998, Acute tolerance associated with a single opiate administration: involvement of N-methyl-d-aspartate-dependent pain facilitatory systems, Neuroscience, 84, 583, 10.1016/S0306-4522(97)00556-3
Laulin, 1998, Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time, The European Journal of Neuroscience, 10, 782, 10.1046/j.1460-9568.1998.00083.x
Celerier, 2001, Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process, The Journal of Neuroscience, 21, 4074, 10.1523/JNEUROSCI.21-11-04074.2001
Laulin, 1999, Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity, Neuroscience, 89, 631, 10.1016/S0306-4522(98)00652-6
Schmid, 1999, Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes, Pain, 82, 111, 10.1016/S0304-3959(99)00044-5
Chia, 1999, The preoperative administration of intravenous dextromethorphan reduces postoperative morphine consumption, Anesthesia and Analgesia, 89, 752, 10.1213/00000539-199909000-00041
Weinbroum, 2003, Preoperative and postoperative dextromethorphan provides sustained reduction in postoperative pain and patient-controlled epidural analgesia requirement: a randomized, placebo-controlled, double-blind study in lower-body bone malignancy-operated patients, Cancer, 97, 2334, 10.1002/cncr.11330
Weinbroum, 2002, Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: a randomized, placebo-controlled, double-blind study, Cancer, 95, 1164, 10.1002/cncr.10784
Bernard, 1991, Postoperative analgesia by intravenous clonidine, Anesthesiology, 75, 577, 10.1097/00000542-199110000-00006
De Kock, 1993, Intravenous or epidural clonidine for intra and postoperative analgesia, Anesthesiology, 79, 525, 10.1097/00000542-199309000-00016
De Kock, 1992, Intraoperative clonidine enhances postoperative morphine patient-controlled analgesia, Canadian Journal of Anaesthesia, 39, 537, 10.1007/BF03008314
Spaulding, 1979, Antinociceptive activity of clonidine and its potentiation of morphine analgesia, European Journal of Pharmacology, 58, 19, 10.1016/0014-2999(79)90335-2
Fairbanks, 1999, Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine, The Journal of Pharmacology and Experimental Therapeutics, 288, 1107
Gowing, 2002, Alpha2-adrenergic agonists in opioid withdrawal, Addiction (Abingdon, England), 97, 49, 10.1046/j.1360-0443.2002.00037.x
Bie, 2003, Roles of a1- and a2-adrenoreceptors in the nucleus raphe magnus in opioid analgesia and opioid abstinence-induced hyperalgesia, The Journal of Neuroscience, 23, 7950, 10.1523/JNEUROSCI.23-21-07950.2003
Joshi, 2003, An evaluation of the safety and efficacy of administering rofecoxib for postoperative pain management, Anesthesia and Analgesia, 97, 35, 10.1213/01.ANE.0000069507.93582.6E
Reuben, 2002, Preemptive analgesic effect of refecoxib after ambulatory arthroscopic knee surgery, Anesthesia and Analgesia, 94, 55, 10.1213/00000539-200201000-00010
Malmberg, 1992, Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition, Science, 257, 1276, 10.1126/science.1381521
Malmberg, 1995, Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats, The Journal of Neuroscience, 15, 2768, 10.1523/JNEUROSCI.15-04-02768.1995
Lee, 1997, Nalbuphine coadministered with morphine prevents tolerance and dependence, Anesthesia and Analgesia, 84, 810, 10.1213/00000539-199704000-00021
Tao, 1994, U-50,488 blocks the development of morphine tolerance and dependence at very low dose in mice, European Journal of Pharmacology, 256, 281, 10.1016/0014-2999(94)90553-3
Yamamoto, 1988, A selective k-agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats, European Journal of Pharmacology, 156, 173, 10.1016/0014-2999(88)90162-8
Likar, 2003, Transdermales Buprenorphin für die Behandlung chronischer Tumor- und Nicht-Tumorschmerzen, Wiener Medizinische Wochenschrift, 153, 317, 10.1046/j.1563-258X.2003.02120.x
Koppert, 2005, Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model, Pain, 118, 15, 10.1016/j.pain.2005.06.030
Bruera, 1996, Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine, Cancer, 78, 852, 10.1002/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T
Mercadante, 1999, Opioid rotation for cancer pain: rationale and clinical aspects, Cancer, 86, 1856, 10.1002/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G
Thomsen, 1999, Opioid rotation in chronic non-malignant pain patients, Acta Anaesthesiologica Scandinavica, 43, 918, 10.1034/j.1399-6576.1999.430909.x
Morley, 1993, Methadone in pain uncontrolled by morphine, Lancet, 342, 1243, 10.1016/0140-6736(93)92228-L
Williams, 1998, Use of methadone in the morphine-tolerant burned paediatric patient, British Journal of Anaesthesia, 80, 92, 10.1093/bja/80.1.92
Kelly, 2001, Preemptive analgesia I: physiological pathways and pharmacolocigal modalities, Canadian Journal of Anaesthesia, 48, 1000, 10.1007/BF03016591
Kelly, 2001, Preemptive analgesia II: recent advances and current trends, Canadian Journal of Anaesthesia, 48, 1091, 10.1007/BF03020375